Vimarsana
Biggest News Aggregation in the World

Page 9 - Corp Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Corp Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Corp Communications Today - Breaking & Trending Today

Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations - Vimarsana News

Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO) and Boston Scientific Corp. (NYSE: BSX) announced today that they have reached a settlement in their ongoing...

Nevro to Present at the Canaccord Genuity 42nd Annual Growth Conference - Vimarsana News

Nevro to Present at the Canaccord Genuity 42nd Annual Growth Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro to Report Second Quarter 2022 Financial Results - Vimarsana News

Nevro to Report Second Quarter 2022 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Clinical Data Presented at American Diabetes Association 82nd Scientific Sessions Reinforce Significant and Durable Benefits of Nevro's HFX 10 kHz Therapy - Vimarsana News

Clinical Data Presented at American Diabetes Association 82nd Scientific Sessions Reinforce Significant and Durable Benefits of Nevro's HFX 10 kHz Therapy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro Announces SENZA-PDN Clinical Data Presentations at the American Diabetes Association 82nd Scientific Sessions - Vimarsana News

Nevro Announces SENZA-PDN Clinical Data Presentations at the American Diabetes Association 82nd Scientific Sessions

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...